Trade ACAD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ACADIA Pharmaceuticals Inc. (ACAD) is trading at US$26.40, down 3.28% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$5.08B. Over the past 52 weeks, ACAD has traded between US$19.69 and US$30.96. On Syfe you can trade ACAD with $0 commission and add it to your watchlist.
| Previous close | US$27.29 |
|---|---|
| Market cap | US$5.08B |
| P/E ratio | 31.67 |
| 52-week range | US$19.69 – US$30.96 |
| Volume | 1.35M |
| Exchange | US |
Add to Watchlist
Set Price Alert
ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Year: 2004
UBS Adjusts Price Target on ACADIA Pharmaceuticals to $49 From $45, Maintains Buy Rating
Aug 17, 1:39 PM · MT Newswires
Acadia Pharmaceuticals to Gain From Daybue, Nuplazid Growth; RADIANT Data Adds Risk, Morgan Stanley Says
Aug 10, 3:33 PM · MT Newswires
Morgan Stanley Adjusts PT on ACADIA Pharmaceuticals to $27 From $26, Maintains Equalweight Rating
Aug 10, 9:25 AM · MT Newswires
ACADIA Pharmaceuticals Inc. (ACAD) stock is trading at US$26.40, -3.28% from the previous close of US$27.29.
The market cap for ACADIA Pharmaceuticals Inc. (ACAD) stock is approximately US$5.08B.
The price-to-earnings ratio for ACADIA Pharmaceuticals Inc. (ACAD) is 31.67, based on the latest reported earnings.
The 52-week high for ACADIA Pharmaceuticals Inc. (ACAD) stock is US$30.96.
The 52-week low for ACADIA Pharmaceuticals Inc. (ACAD) stock is US$19.69.
ACADIA Pharmaceuticals Inc. (ACAD) does not currently pay a dividend.
Stay on top of ACAD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
